2008
DOI: 10.1016/j.chembiol.2008.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Covalent and Noncovalent Intermediates of an NAD Utilizing Enzyme, Human CD38

Abstract: SUMMARY Enzymatic utilization of nicotinamide adenine dinucleotide (NAD) has increasingly been shown to have fundamental roles in gene regulation, signal transduction, and protein modification. Many of the processes require the cleavage of the nicotinamide moiety from the substrate and the formation of a reactive intermediate. Using X-ray crystallography we show that human CD38, an NAD utilizing enzyme, is capable of catalyzing the cleavage reactions through both covalent and non-covalent intermediates, depend… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
58
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
6
2

Relationship

5
3

Authors

Journals

citations
Cited by 41 publications
(62 citation statements)
references
References 52 publications
4
58
0
Order By: Relevance
“…This observation was also seen in the structures of human CD38, the homolog of Aplysia cyclase. [18][19][20] The results represent the first time ever that a fully active Aplysia cyclase has been observed with an NAD + molecule, its natural substrate, or an NGD + molecule, a close analog of NAD + , bound at the active site. The results also validate our approach of selecting crystals with multiple cyclase molecules in the asymmetric unit for analysis.…”
Section: Overview Of Complex Structuresmentioning
confidence: 87%
See 1 more Smart Citation
“…This observation was also seen in the structures of human CD38, the homolog of Aplysia cyclase. [18][19][20] The results represent the first time ever that a fully active Aplysia cyclase has been observed with an NAD + molecule, its natural substrate, or an NGD + molecule, a close analog of NAD + , bound at the active site. The results also validate our approach of selecting crystals with multiple cyclase molecules in the asymmetric unit for analysis.…”
Section: Overview Of Complex Structuresmentioning
confidence: 87%
“…14 To decipher details of the cyclization reaction by Aplysia cyclase and to understand the structural differences conferring its homolog human CD38 to be more of an NAD + hydrolase than cyclase (i.e., converting NAD + to a linear ADPR instead of the cyclic product, cADPR), we have performed extensive kinetic crystallographic studies to attempt to arrest the reaction at specific steps. 12,13,[15][16][17][18][19][20][21] In most cases, the crystals of both proteins contained two molecules per asymmetric unit, and even though different states of the reaction intermediate can be captured in the two molecules, it could not provide us with a comprehensive picture about the progress of the reaction. Interestingly, Aplysia cyclase and human CD38 have the ability to crystallize in different crystal forms, some of which contain multiple subunits of the protein in the asymmetric unit.…”
Section: Introductionmentioning
confidence: 98%
“…To visualize the cyclization process, however, we had to choose an appropriate substrate that can form a stable complex with the cyclase without being consumed and released as product. One possibility is ara-2ЈF-NMN, which has been shown to form a covalent intermediate with CD38 and inhibit its enzyme activity (33,34). However, ara-2ЈF-NMN cannot form a cyclic product because it is missing the adenine group.…”
Section: Resultsmentioning
confidence: 99%
“…An intermediate is formed. Both covalent [124] and non-covalent [123,124] intermediates of CD38 have been observed, depending on the substrate. With arabinosyl-2′-fluoro-deoxy-nicotinamide adenine dinucleotide (ara-2′F-NAD) as substrate, an analog of NAD, Glu226 forms a covalent linkage with the anomeric carbon (C1R) of the terminal ribose [125], as shown in Figures 3 and 4.…”
Section: Structure and Catalytic Mechanism Of Cd38mentioning
confidence: 99%